Paper3992249
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
Mash DC and 2 others. Science, 1985. Cited by 647 papers, by iCite.
Cite this record
ConductScience Library. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Papers, record 3992249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3992249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cerebral Cortex | Major topic |
| Choline O-Acetyltransferase | Major topic |
| Receptors, Muscarinic | Major topic |
| Synaptic Membranes | Major topic |
| Aged | |
| Animals | |
| Cholinergic Fibers | |
| Denervation | |
| Humans | |
| Male | |
| Oxotremorine | |
| Quinuclidinyl Benzilate | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HLO-7188 | NHLBI NIH HHS | United States | PubMed | PubMed | |
| T32HL007188 | NIH | NIH RePORTER |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 647 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42614314 | Emerging neuroprotective mechanisms and therapeutic potential of natural polysaccharides in Alzheimer's disease. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42614314 | PubMed |
| 41990387 | Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity. | Annu Rev Neurosci | 2026 | https://conductscience.org/library/papers/41990387 | PubMed |
| 40495777 | Combined Effects of Intermittent Hypoxia and Amyloid Beta on Hippocampal Activity, Its Cholinergic Modulation, and Memory. | Hippocampus | 2025 | https://conductscience.org/library/papers/40495777 | PubMed |
| 40237061 | Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease. | Curr Neuropharmacol | 2025 | https://conductscience.org/library/papers/40237061 | PubMed |
| 40133398 | Agarwood leaf ethanol extract provides neuroprotective properties and promotes cholinergic differentiation of HT22 hippocampal neurons. | Sci Rep | 2025 | https://conductscience.org/library/papers/40133398 | PubMed |
| 39039673 | Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies. | Curr Drug Targets | 2024 | https://conductscience.org/library/papers/39039673 | PubMed |
| 38578893 | Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38578893 | PubMed |
| 34450027 | Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. | Cell | 2021 | https://conductscience.org/library/papers/34450027 | PubMed |
| 34272732 | Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance. | J Neurochem | 2021 | https://conductscience.org/library/papers/34272732 | PubMed |
| 34164794 | Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects. | Drugs R D | 2021 | https://conductscience.org/library/papers/34164794 | PubMed |
| 34037379 | Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. | ACS Chem Neurosci | 2021 | https://conductscience.org/library/papers/34037379 | PubMed |
| 33931975 | Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/33931975 | PubMed |
| 33891333 | Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33891333 | PubMed |
| 33790746 | Neuromodulation of Persistent Activity and Working Memory Circuitry in Primate Prefrontal Cortex by Muscarinic Receptors. | Front Neural Circuits | 2021 | https://conductscience.org/library/papers/33790746 | PubMed |
| 33627325 | The Property-Based Practical Applications and Solutions of Genetically Encoded Acetylcholine and Monoamine Sensors. | J Neurosci | 2021 | https://conductscience.org/library/papers/33627325 | PubMed |
| 33351971 | First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/33351971 | PubMed |
| 33342413 | Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors. | Curr Neuropharmacol | 2021 | https://conductscience.org/library/papers/33342413 | PubMed |
| 33277628 | Genetically encoded sensors enable micro- and nano-scopic decoding of transmission in healthy and diseased brains. | Mol Psychiatry | 2021 | https://conductscience.org/library/papers/33277628 | PubMed |
| 32766549 | M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer's disease pathology. | Brain Commun | 2020 | https://conductscience.org/library/papers/32766549 | PubMed |
| 32396366 | Nanoscopic Visualization of Restricted Nonvolume Cholinergic and Monoaminergic Transmission with Genetically Encoded Sensors. | Nano Lett | 2020 | https://conductscience.org/library/papers/32396366 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CHAT | 1103 | PubTator's text mining | https://conductscience.org/library/genes/1103 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3992249
GET https://conductscience.org/api/papers/v1/3992249/cited_by?page=2